Twitter and Tesla CEO Elon Musk announced a big development Wednesday in the brain chip innovation by his company Neuralink. The business mogul said the wireless device, which would be implanted in ...
Company advancing toward submitting Investigational Device Exemption (“IDE”), and if approved, will commence a pivotal clinical trial to support a De Novo application for FDA approval Mr. Hauser added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback